Mira Pharmaceuticals (MIRA) Retained Earnings (2022 - 2025)

Mira Pharmaceuticals (MIRA) has 4 years of Retained Earnings data on file, last reported at -$39.6 million in Q4 2025.

• Quarterly Retained Earnings fell 35.84% year-over-year to -$39.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$39.6 million (down 35.84% YoY) and the FY2025 annual result came in at -$39.6 million, down 35.84% from the prior year.
• Retained Earnings fell to -$39.6 million in Q4 2025 per MIRA's latest filing, from -$33.6 million in the prior quarter.
• The five-year high for Retained Earnings was -$9.3 million in Q4 2022, with the low at -$39.6 million in Q4 2025.
• Average Retained Earnings over 4 years is -$24.9 million, with a median of -$26.7 million recorded in 2024.
• Year-over-year, Retained Earnings tumbled 128.8% in 2023 and declined 25.65% in 2025.
• Mira Pharmaceuticals' Retained Earnings stood at -$9.3 million in 2022, then plunged by 128.8% to -$21.3 million in 2023, then slumped by 36.89% to -$29.1 million in 2024, then tumbled by 35.84% to -$39.6 million in 2025.
• Business Quant data shows MIRA's Retained Earnings at -$39.6 million in Q4 2025, -$33.6 million in Q3 2025, and -$32.5 million in Q2 2025.